Elanco Animal Health said Monday it expects to launch a product in the third quarter that reduces methane emissions in lactating dairy cattle. The Greenfield-based company said the U.S. Food and Drug Administration has completed its review of Bovaer.... Read More
Faced with overwhelming demand for its diabetes treatment Mounjaro and weight-loss treatment Zepbound, Indianapolis-based drugmaker Eli Lilly and Co. said Friday it plans to invest another $5.3 billion in its brand-new Boone County manufacturing complex.... Read More
A Swiss-based drugmaker plans to double the size of its Indianapolis manufacturing plant, which produces nuclear medicine imaging and therapy products for cancer, in a move that would create 55 jobs with an average wage of $95,000.... Read More
Butler University is setting up a bachelor of science in nursing program, a four-year program that marks the university’s first foray into nursing as Indiana faces a growing workforce crunch in the field. The school said it will accept applications on...... Read More
Eli Lilly and Co. has entered a settlement agreement with a South Carolina medical spa that was selling knockoff versions of its popular diabetes treatment Mounjaro and weight-loss treatment Zepbound. The agreement with Totality Medispa included an...... Read More
Indiana’s hospital prices remain among the highest in the nation, according to the latest study conducted by research group Rand Corp. released Monday morning. Indiana employers and employees are paying nearly three times, or 297%, what Medicare pays for...... Read More
To environmentalists, the scores of coal ash ponds that have sprung up around Indiana power plants over the decades are a looming threat to public health and water supplies. Most are near rivers and filled with toxic chemicals, including arsenic and mercury.... Read More
Indiana’s life sciences companies landed $5.5 billion in capital and investments last year from all sources, down 19% from a year earlier. That figure includes funds raised through venture capital and other sources, according to a report by BioCrossroads.... Read More
More than four years after the start of the COVID-19 pandemic, many Indiana hospitals are still barely breaking even and their financial viability remains at risk, according to a report released Thursday morning by the Indiana Hospital Association.... Read More
Eli Lilly and Co. said Tuesday that “exceptionally strong demand” for diabetes drugs Mounjaro and weight-loss drug Zepbound helped push first quarter profit up 67%, but warned that it expects tight supplies of both drugs to continue.... Read More
